Can China achieve a one-third reduction in premature mortality from non-communicable diseases by 2030?

BMC Medicine

Volumn 15, Issue 1, 2017, Pages

  Li, Yichong ^a   Zeng, Xinying ^a   Liu, Jiangmei ^a   Liu, Yunning ^a   Liu, Shiwei ^a   Yin, Peng ^a   Qi, Jinlei ^a   Zhao, Zhenping ^a   Yu, Shicheng ^a   Hu, Yuehua ^a   He, Guangxue ^a   Lopez, Alan D ^b   Gao, George F ^a   Wang, Linhong ^a   Zhou, Maigeng ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chronic disease; Forecasting; Mortality, Premature; Risk factors

Indexed keywords

CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHINA; CHOLESTEROL BLOOD LEVEL; CHRONIC RESPIRATORY TRACT DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; NON COMMUNICABLE DISEASE; PHYSICAL INACTIVITY; PREMATURE MORTALITY; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; WORLD HEALTH ORGANIZATION; AGED; CHRONIC DISEASE; FORECASTING; MIDDLE AGED; MORTALITY; NEOPLASM; PATIENT CARE PLANNING; TRENDS;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHINA; CHRONIC DISEASE; DIABETES MELLITUS; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; MORTALITY, PREMATURE; NEOPLASMS; PATIENT CARE PLANNING; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING;

EID: 85026203410     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-017-0894-5     Document Type: Article

References (34)

1. Wang L, Kong L, Wu F, Bai Y, Burton R. Preventing chronic diseases in China. Lancet. 2005;366(9499):1821-4.
2. Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387(10015):251-72.
3. Li Y, Zhang M, Jiang Y, Wu F. Co-variations and clustering of chronic disease behavioral risk factors in China: China Chronic Disease and Risk Factor Surveillance, 2007. PLoS One. 2012;7(3):e33881.
4. Li Y, Wang L, Jiang Y, Zhang M, Wang L. Risk factors for noncommunicable chronic diseases in women in China: surveillance efforts. Bull World Health Organ. 2013;91(9):650-60.
5. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948-59.
6. Xi B, Liang Y, Reilly KH, Wang Q, Hu Y, Tang W. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991-2009. Int J Cardiol. 2012;158(2):326-9.
7. Wu Y. Overweight and obesity in China. BMJ. 2006;333(7564):362-3.
8. UN General Assembly. Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. United Nations A/66/L.1. Sept 16, 2011. http://www.un.org/ga/search/view_doc.asp?symbol=A/66/L.1. Accessed 20 July 2016.
9. WHO. 65th World Health Assembly. WHA65(8) Prevention and control of noncommunicable diseases: follow-up to the High-level meeting of the United Nations General Assembly on the Prevention and Control of Non-communicable diseases. June 5, 2012. http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_DIV3-en.pdf. Accessed 10 April 2016.
10. United Nations. Sustainable development goals. Goal 3: Ensure healthy lives and promote well-being for all at all ages. http://www.un.org/sustainabledevelopment/health/. Accessed 20 July 2016.
11. WHO. Monitoring framework and targets for the prevention and control of NCDs. Revised WHO discussion paper on the development of a comprehensive global monitoring framework, including indicators, and a set of voluntary global targets for the prevention and control of NCDs. July 25, 2012. http://www.who.int/nmh/events/2012/ncd_discussion_paper/en. Accessed 10 April 2016.
12. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71.
13. Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287-323.
14. World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: WHO Press; 2014.
15. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118(25):2679-86.
16. National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention. Report on Chronic Disease Risk Factor Surveillance in China, 2013. Beijing: Military Medical Science Press; 2016. (In Chinese).
17. Mendis S, Lindholm LH, Mancia G, Whitworth J, Alderman M, Lim S, et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens. 2007;25(8):1578-82.
18. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438-47.
19. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25):e510-26.
20. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet. 2012;380(9842):668-79.
21. Yang G, Ma J, Chen A, Zhang Y, Samet JM, Taylor CE, et al. Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control. 2001;10(2):170-4.
22. Chen Z, Peto R, Zhou M, Iona A, Smith M, Yang L, et al. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet. 2015;386(10002):1447-56.
23. Yang G, Wang Y, Wu Y, Yang J, Wan X. The road to effective tobacco control in China. Lancet. 2015;385(9972):1019-28.
24. Hu TW, Lee AH, Mao Z. WHO Framework Convention on Tobacco Control in China: barriers, challenges and recommendations. Glob Health Promot. 2013;20(4):13-22.
25. The impacts of tobacco tax increase. http://www.cb.com.cn/special/show/810.html. Accessed 18 April 2017. (In Chinese).
26. Lakhdar CB. Quantitative and qualitative estimates of cross-border tobacco shopping and tobacco smuggling in France. Tob Control. 2008;17(1):12-6.
27. Choi SE. Are lower income smokers more price sensitive? The evidence from Korean cigarette tax increases. Tob Control. 2016;25(2):141-6.
28. Xi B, Liang Y, He T, Reilly KH, Hu Y, Wang Q, et al. Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993-2009. Obes Rev. 2012;13(3):287-96.
29. National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention. Report on Chronic Disease Risk Factor Surveillance in China, 2010. Beijing: Military Medical Science Press; 2010. (In Chinese.)
30. Zhai F, Wang H, Du S, He Y, Wang Z, Ge K, et al. Prospective study on nutrition transition in China. Nutr Rev. 2009;67 Suppl 1:S56-61.
31. Chen Z, Lee L, Chen J, Collins R, Wu F, Guo Y, et al. Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC). Int J Epidemiol. 2005;34(6):1243-9.
32. Shu XO, Li H, Yang G, Gao J, Cai H, Takata Y, et al. Cohort profile: the Shanghai Men's Health Study. Int J Epidemiol. 2015;44(3):810-8.
33. Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol. 2005;162(11):1123-31.
34. Wang X, Lu M, Qian J, Yang Y, Li S, Lu D, et al. Rationales, design and recruitment of the Taizhou Longitudinal Study. BMC Public Health. 2009;9:223.